Compass Biotechnologies Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Compass Biotechnologies prevailing Real Value cannot be determined due to lack of data. The current price of Compass Biotechnologies is $0.0. Our model approximates the value of Compass Biotechnologies from analyzing the firm fundamentals such as EBITDA of (708.94 K), return on asset of -0.0336, and Shares Outstanding of 1.43 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Compass Biotechnologies' valuation include:
Undervalued
Today
Please note that Compass Biotechnologies' price fluctuation is out of control at this time. Calculation of the real value of Compass Biotechnologies is based on 3 months time horizon. Increasing Compass Biotechnologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Compass Biotechnologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Compass Stock. However, Compass Biotechnologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The intrinsic value of Compass Biotechnologies' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Compass Biotechnologies' stock price.
Estimating the potential upside or downside of Compass Biotechnologies helps investors to forecast how Compass stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Compass Biotechnologies more accurately as focusing exclusively on Compass Biotechnologies' fundamentals will not take into account other important factors: When choosing an evaluation method for Compass Biotechnologies, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Compass Biotechnologies Cash |
|
Compass Biotechnologies Total Value Analysis
Compass Biotechnologies is currently forecasted to have valuation of 288.1 K with market capitalization of 14.28 K, debt of 78.19 K, and cash on hands of 31.21 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Compass Biotechnologies fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
288.1 K | 14.28 K | 78.19 K | 31.21 K |
Compass Biotechnologies Asset Utilization
One of the ways to look at asset utilization of Compass is to check how much profit was generated for every dollar of assets it reports. Compass Biotechnologies shows a negative utilization of assets of -0.0336 percent, losing $3.36E-4 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Compass Biotechnologies shows how discouraging it operates for each dollar spent on its assets.Compass Biotechnologies Profitability Analysis
Net Loss for the year was (323.81 K) with profit before overhead, payroll, taxes, and interest of 0.About Compass Biotechnologies Valuation
An absolute valuation paradigm, as applied to Compass Stock, attempts to find the value of Compass Biotechnologies based on its fundamental and basic technical indicators. By analyzing Compass Biotechnologies's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Compass Biotechnologies's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compass Biotechnologies. We calculate exposure to Compass Biotechnologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Compass Biotechnologies's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit Margin | 0.64 | 0.65 |
Compass Biotechnologies Current Valuation Indicators
Valuation refers to the process of determining the present value of Compass Biotechnologies and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Compass we look at many different elements of the entity such as Compass's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Compass Biotechnologies, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Compass Biotechnologies' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Compass Biotechnologies' worth.Complementary Tools for Compass Stock analysis
When running Compass Biotechnologies' price analysis, check to measure Compass Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Biotechnologies is operating at the current time. Most of Compass Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Compass Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Biotechnologies' price. Additionally, you may evaluate how the addition of Compass Biotechnologies to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |